Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations
暂无分享,去创建一个
Cisca Wijmenga | Alessandro Ventura | Jukka Partanen | Katri Kaukinen | Tarcisio Not | C. Wijmenga | R. Ádány | J. Romanos | M. Bardella | K. Kaukinen | I. Korponay-Szabó | M. Mäki | D. Barisani | P. Saavalainen | J. Partanen | K. Mustalahti | T. Not | A. Ventura | Jihane Romanos | Maria Teresa Bardella | Donatella Barisani | Róza Ádány | Markku Mäki | Kirsi Mustalahti | G. Széles | Z. Pocsai | Lotta Koskinen | Ilma Korponay-Szabo | Fabiana Ziberna | Serena Vatta | György Széles | Zsuzsa Pocsai | Kati Karell | Katri Haimila | Päivi Saavalainen | F. Ziberna | S. Vatta | L. Koskinen | K. Haimila | K. Karell
[1] M. Mazzilli,et al. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ(α1∗0501, β1∗0201) heterodimer , 1992 .
[2] M. Mearin,et al. Coeliac disease: is it time for mass screening? , 2005, Best practice & research. Clinical gastroenterology.
[3] Pardis C Sabeti,et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.
[4] R. Ádány,et al. A preliminary evaluation of a health monitoring programme in Hungary. , 2005, European journal of public health.
[5] J R O'Connell,et al. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.
[6] J. Partanen,et al. Major histocompatibility complex (MHC)-linked microsatellite markers in a founder population. , 2000, Tissue antigens.
[7] K. Kaukinen,et al. HLA-DQ typing in the diagnosis of celiac disease , 2002, American Journal of Gastroenterology.
[8] J. Vandenbroucke,et al. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. , 2000, The Journal of pediatrics.
[9] S. Guandalini,et al. Revised criteria for diagnosis of coeliac disease , 1990 .
[10] E. Thorsby,et al. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. , 1993, Gastroenterology.
[11] E. Thorsby,et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer , 1989, The Journal of experimental medicine.
[12] M. Mäki,et al. Coeliac Disease among Healthy Members of Multiple Case Coeliac Disease Families , 2002, Scandinavian journal of gastroenterology.
[13] E. Thorsby,et al. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. , 1992, Human immunology.
[14] M. Rewers,et al. Two Single Nucleotide Polymorphisms Identify the Highest-Risk Diabetes HLA Genotype , 2008, Diabetes.
[15] C. Wijmenga,et al. Molecular diagnosis of celiac disease: are we there yet? , 2008, Expert opinion on medical diagnostics.
[16] F. Koning,et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Mazzilli,et al. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ(alpha 1*0501, beta 1*0201) heterodimer. , 1992, Human immunology.
[18] E. Thorsby,et al. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. , 1993, Tissue antigens.
[19] C. Wijmenga,et al. Myosin IXB gene region and gluten intolerance: linkage to coeliac disease and a putative dermatitis herpetiformis association , 2007, Journal of Medical Genetics.
[20] B. Lie,et al. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. , 2002, Tissue antigens.
[21] J. Partanen,et al. HLA DQ AND DP IN FINNISH FAMILIES WITH CELIAC DISEASE , 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[22] J. Hugot,et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. , 2004, Tissue antigens.
[23] M. Mäki,et al. Gluten-free diet and quality of life in patients with screen-detected celiac disease. , 2002, Effective clinical practice : ECP.
[24] L. Fugger,et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease , 1998, Nature Medicine.
[25] L. Greco,et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. , 2003, Human immunology.
[26] Cisca Wijmenga,et al. Effective Detection of Human Leukocyte Antigen Risk Alleles in Celiac Disease Using Tag Single Nucleotide Polymorphisms , 2008, PloS one.
[27] E. G. de la Concha,et al. HLA-DQ2-negative celiac disease in Finland and Spain. , 1998, Human immunology.
[28] R. Ophoff,et al. Detection, imputation, and association analysis of small deletions and null alleles on oligonucleotide arrays. , 2008, American journal of human genetics.
[29] Marian Rewers,et al. Two Single Nucleotide Polymorphisms Identify Highest-Risk Diabetes Human Leukocyte Antigen Genotype: Potential for Rapid Screening , 2008 .
[30] G. Oberhuber,et al. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. , 1999, European journal of gastroenterology & hepatology.